Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Obesity Reports
Erschienen in: Current Obesity Reports 3/2015

01.09.2015 | Health Services and Programs (SFL Kirk, Section Editor)

An Overview of Links Between Obesity and Mental Health

verfasst von: Christian Avila, Alison C. Holloway, Margaret K. Hahn, Katherine M. Morrison, Maria Restivo, Rebecca Anglin, Valerie H. Taylor

Erschienen in: Current Obesity Reports | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The American Medical Association recently recognized obesity as both an illness and a leading cause of preventable death and chronic disease. This association is not only linked to physical health outcomes, however, as obesity has also been extensively associated with mental illness as well. Both obesity and severe mental illness decrease quality of life and are associated with an increase in disability, morbidity, and mortality, and when they occur together, these adverse health outcomes are magnified. Despite educational campaigns, increased awareness, and improved treatment options, the high prevalence of mental illness and comorbid obesity remains a serious problem. This review examines this overlap, highlighting clinical and biological factors that have been linked to this association in order to improve our understanding and help elucidate potential therapeutic avenues.
Literatur
1.
2.
Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–50.PubMedCrossRef
3.
Gadalla TM. Association of obesity with mood and anxiety disorders in the adult general population. Chronic Dis Can. 2009;30(1):29–36.PubMed
4.
Vanasse A, Demers M, Hemiari A, et al. Obesity in Canada: where and how many? Int J Obes. 2006;30:677–83.CrossRef
5.
Wilborn C, Beckham J, Campbell B, et al. Obesity: prevalence, theories, medical consequences, management, and research directions. J Int Soc Sports Nutr. 2005;2:4–31.PubMedCentralPubMedCrossRef
6.
7.
Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013;11(9):639–47.PubMedCrossRef
8.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Fifth ed.). Arlington: American Psychiatric Publishing; 2013. p. 5–25.
9.
Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One. 2014;9(4):e91936.PubMedCentralPubMedCrossRef
10.
Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-47, HHS Publication No. (SMA) 13-4805. Rockville: Substance Abuse and Mental Health Services Administration; 2013. http://​store.​samhsa.​gov/​home.
11.
Kivimäki M, Batty GD, Singh-Manoux A, et al. Association between common mental disorder and obesity over the adult life course. Br J Psychiatry. 2009;195(2):149–55.PubMedCentralPubMedCrossRef
12.
13.
Cameron AJ, Magliano DJ, Dunstan DW, et al. A bi-directional relationship between obesity and health-related quality of life: evidence from the longitudinal AusDiab study. Int J Obes (Lond). 2012;36(2):295–303.CrossRef
14.
De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.
15.
Remington G. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining? Am J Psychiatry. 2006;163(7):1132–4.PubMedCrossRef
16.
17.
Fliers EA, Buitelaar JK, Maras A, et al. ADHD is a risk factor for overweight and obesity in children. J Dev Behav Pediatr. 2013;34(8):566–74.PubMedCrossRef
18.
Pagoto SL, Curtin C, Lemon SC, et al. Association between adult attention deficit/hyperactivity disorder and obesity in the US population. Obesity. 2009;17(3):539–44.PubMedCentralPubMedCrossRef
19.•
Taylor VH, McIntyre RS, Remington G, et al. Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness. Can J Psychiatry. 2012;57(1):5–12. This review elucidate the complex interplay between psychiatric illness and weight gain.PubMed
20.
Cook BG, Li D, Heinrich KM. Obesity, physical activity, and sedentary behavior of youth with learning disabilities and ADHD. J Learn Disabil. 2014.
21.
Harvey WJ, Reid G, Grizenko N, et al. Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects. J Abnorm Child Psychol. 2007;35(5):871–82.PubMedCrossRef
22.
Harvey WJ, Reid G, Bloom GA, et al. Physical activity experiences of boys with and without ADHD. Adapt Phys Act Q. 2009;26:131–50.
23.
Cortese S, Angriman M, Maffeis C, et al. Attention deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit Rev Food Sci Nutr. 2008;48(6):524–37.PubMedCrossRef
24.
Levitan RD, Masellis M, Lam RW, et al. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology. 2004;29(1):179–86.PubMedCrossRef
25.
Comings DE, Blum K. Reward deficiency syndrome: genetics aspects of behavioral disorders. Prog Brain Res. 2000;126:325–41.PubMedCrossRef
26.
Hudson JI, Lalonde JK, Berry JM, et al. Binge-eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry. 2006;63(3):313–9.PubMedCrossRef
27.
Stanford C, Tannock R. Obesity and ADHD: clinical and neurobiological implications. In: Behavioral neuroscience of attention deficit hyperactivity disorder and its treatment. Ed Springer; 2012.
28.
Ranjba S, Deng C. The association of antidepressant medication and body weight gain. Online J Health Allied Sci Mangalore South India. 2013;12:ISSN 0972-5997.
29.
Hall KS, Hoerster KD, Yancy WS Jr. Post-traumatic stress disorder, physical activity, and eating behaviors. Epidemiol Rev. 2015.
30.
Mitchell KS, Aiello AE, Galea S, et al. PTSD and obesity in the Detroit neighborhood health study. Gen Hosp Psychiatry. 2013;35(6):671–3.PubMedCrossRef
31.
Kubzansky LD, Bordelois P, Jun HJ, et al. The weight of traumatic stress: a prospective study of posttraumatic stress disorder symptoms and weight status in women. JAMA Psychiatry. 2014;71(1):44–51.PubMedCentralPubMedCrossRef
32.•
Maguen S, Madden E, Cohen B, et al. The relationship between body mass index and mental health among Iraq and Afghanistan veterans. J Gen Intern Med. 2013;28 Suppl 2:S563–70. This study evaluated almost 500.000 veterans exploring the relationship between body mass index and posttraumatic stress disorder over 3 years.PubMedCrossRef
33.
Smith TJ, White A, Hadden L, et al. Associations between mental health disorders and body mass index among military personnel. Am J Health Behav. 2014;38(4):529–40.PubMedCrossRef
34.
Babić R, Maslov B, Babić D, et al. The prevalence of metabolic syndrome in patient with posttraumatic stress disorder. Psychiatr Danub. 2013;25 Suppl 1:45–50.PubMed
35.
Roenholt S, Beck NN, Karsberg SH, et al. Post-traumatic stress symptoms and childhood abuse categories in a national representative sample for a specific age group: associations to body mass index. Eur J Psychotraumatol. 2012;3(17188):1–9.
36.
Williamson DF, Thompson TJ, Anda RF, et al. Body weight and obesity in adults and self-reported abuse in childhood. Int J Obes Relat Metab Disord. 2002;26(8):1075–82.PubMedCrossRef
37.
D’Argenio A, Mazzi C, Pecchioli L, et al. Early trauma and adult obesity: is psychological dysfunction the mediating mechanism? Physiol Behav. 2009;98(5):543–6.PubMedCrossRef
38.
39.
de Assis MA, de Mello MF, Scorza FA, et al. Evaluation of physical activity habits in patients with posttraumatic stress disorder. Clinics (Sao Paulo). 2008;63(4):473–8.CrossRef
40.
Hirth JM, Rahman M, Berenson AB. The association of posttraumatic stress disorder with fast food and soda consumption and unhealthy weight loss behaviors among young women. J Womens Health (Larchmt). 2011;20(8):1141–9.CrossRef
41.
Russell E, Koren G, Rieder M, et al. Hair cortisol as a biological marker of chronic stress:current status, future directions and unanswered questions. Psychoneuroendocrinology. 2012;37(5):589–601.PubMedCrossRef
42.
Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 2007;13(7):803–11.PubMedCrossRef
43.
Mason SM, Flint AJ, Roberts AL, et al. Posttraumatic stress disorder symptoms and food addiction in women by timing and type of trauma exposure. JAMA Psychiatry. 2014;71:1271–8.PubMedCrossRef
44.
Weiner M, Warren L, Fiedorowickz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23(1):40–7.PubMedCentralPubMed
45.
Opel N, Redlich R, Grotegerd D, et al. Obesity and major depression: body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology. 2015;51:219–26.PubMedCrossRef
46.
Liu CS, Carvalho AF, McIntyre RS. Towards a “metabolic” subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction. CNS Neurol Disord Drug Targets. 2014;13(10):1693–707.PubMedCrossRef
47.
Taylor V, MacQueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry. 2006;67(7):1034–41.PubMedCrossRef
48.
Musselman DL, Betan E, Larsen H, et al. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003;54(3):317–29.PubMedCrossRef
49.
Mansur RB, Brietzke E, McIntyre RS. Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neurosci Biobehav Rev. 2015.
50.
Brumby S, Chandrasekara A, Kremer P, et al. The effect of physical activity on psychological distress, cortisol and obesity: results of the Farming Fit intervention program. BMC Public Health. 2013;13:1018.PubMedCentralPubMedCrossRef
51.
52.
Shelton RC, Miller AH. Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci. 2011;13(1):41–53.PubMed
53.
Palinkas LA, Wingard DL, Barrett-Connor E. Depressive symptoms in overweight and obese older adults: a test of the ‘jolly fat’ hypothesis. J Psychosom Res. 1996;40:59–66.PubMedCrossRef
54.
Lago F, Dieguez C, Gómez-Reino J, et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3(12):716–24.PubMedCrossRef
55.
Degawa-Yamauchi M, Moss KA, Bovenkerk JE, et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res. 2005;13(4):662–9.PubMedCrossRef
56.
Taylor VH, MacQueen GM. The role of adipokines in understanding the associations between obesity and depression. J Obes. 2010;2010.
57.
De Wit L, Luppino F, van Straten A, et al. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res. 2010;178(2):230–5.PubMedCrossRef
58.
Soczynska JK, Kennedy SH, Woldeyohannes O, et al. Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromol Med. 2011;13:93–116.CrossRef
59.
Dent R, Blackmore A, Peterson J, et al. Changes in body weight and psychotropic drugs: a systematic synthesis of the literature. PLoS One. 2012;7(6):e36889.PubMedCentralPubMedCrossRef
60.
Kemp DE. Managing the side effects associated with commonly used treatments for bipolar depression. J Affect Disord. 2014;169S1:S34–44.CrossRef
61.
62.
63.
Hsu WY, Lane HY, Lin CL, et al. A population-based cohort study on deep vein thrombosis and pulmonary embolism among schizophrenia patients. Schizophr Res. 2015;162(1–3):248–52.PubMedCrossRef
64.
Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. Clin Psychiatry. 2002;63 suppl 9:5–11.
65.
Jeste DV, Gladsjo JA, Lindamer LA, et al. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22:412–30.CrossRef
66.
Kohen D. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry Suppl. 2004;47:S64–6.PubMedCrossRef
67.
Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry. 2006;14(4):212–22.PubMedCrossRef
68.
Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19 Suppl 1:1–93.PubMed
69.
Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004;161(3):414–25.PubMedCrossRef
70.
Zipursky RB, Gu H, Green AI, et al. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry. 2005;187:537–43.PubMedCrossRef
71.
Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–73.PubMedCentralPubMedCrossRef
72.
Alvarez-Jimenez M, Gonzalez-Blanch C, Crespo-Facorro B, Hetrick S, Rodriguez-Sanchez JM, Perez-Iglesias R, et al. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs. 2008;22(7):547–62.PubMedCrossRef
73.
74.
Britvic D, Maric NP, Doknic M. Metabolic issues in psychotic disorders with the focus on first-episode patients: a review. Psychiatr Danub. 2013;25(4):410–5.PubMed
75.
76.
Lencz T et al. DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics. 2010;20:569–72.PubMedCentralPubMedCrossRef
77.
Cowley MA, Cone R, Enriori P, et al. Electrophysiological actions of peripheral hormones on melanocortin neurons. Ann N Y Acad Sci. 2003;994:175–86.PubMedCrossRef
78.
Zhou L, Williams T, Lachey JL, et al. Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides. 2005;26(10):1728–32. Review.PubMedCrossRef
79.
Taveira TH, Wu WC, Tschibelu E, et al. The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study. J Psychopharmacol. 2014;28(4):395–400.PubMedCrossRef
80.
Nothdurfter C, Schmotz C, Sarubin N, et al. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness. J Psychiatr Res. 2014;52:15–20.PubMedCrossRef
81.
De Silva PN. Does the association with diabetes say more about schizophrenia and its treatment?--the GLUT hypothesis. Med Hypotheses. 2011;77(4):529–31.PubMedCrossRef
82.
Chintoh AF, Mann SW, Lam L, et al. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophr Res. 2009;108(1–3):127–33.PubMedCrossRef
83.
Hahn M, Chintoh A, Giacca A, et al. Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model. Schizophr Res. 2011;131(1–3):90–5.PubMedCrossRef
84.•
Ballon JS, Pajvani U, Freyberg Z, et al. Molecular pathophysiology of metabolic effects of antipsychotic medications. Trends Endocrinol Metab. 2014;25(11):593–600. This manuscript describes antipsychotics putative mechanisms on weight gain as well as metabolic risks of schizophrenia itself.PubMedCrossRef
85.
Stone WS, Faraone SV, Su J, et al. Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Am J Med Genet B Neuropsychiatr Genet. 2004;127B(1):5–10.PubMedCrossRef
86.
Sahoo S, Ameen S, Akhtar S. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics. Aust N Z J Psychiatry. 2007;41(7):629.PubMed
87.
88.
De Domingo Bartolomé M, López Guzmán J. The social stigma of obesity. Cuad Bioet. 2014;25(84):273–84.PubMed
89.
90.
Marcus M, Wildes J. Obesity in DSM-5. Psychiatr Ann. 2012;42:431–5.CrossRef
91.
Manasse SM, Forman EM, Ruocco AC, et al. Do executive functioning deficits underpin binge eating disorder? A comparison of overweight women with and without binge eating pathology. Int J Eat Disord. 2015.
92.
Mauro M, Taylor V, Wharton S, et al. Barriers to obesity treatment. Eur J Intern Med. 2008;19(3):173–80.PubMedCrossRef
93.
Barry D, Clarke M, Petry M. Obesity and its relationship to addictions: is overeating a form of addictive behavior? Am J Addict. 2009;18(6):439–51.PubMedCentralPubMedCrossRef
94.
Swinburn BA, Caterson I, Seidell JC, et al. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004;7:123–46.PubMed
95.
Fairburn C, Brownell K. Eating disorders and obesity: a comprehensive handbook. 2002.
96.
Schreiber LR, Odlaug BL, Grant JE. The overlap between binge eating disorder and substance use disorders: diagnosis and neurobiology. J Behav Addict. 2013;2(4):191–8.PubMedCentralPubMedCrossRef
97.
Goracci A, Casamassima F, Iovieno N, et al. Binge eating disorder: from clinical research to clinical practice. J Addict Med. 2015;9(1):20–4.PubMedCrossRef
Metadaten
Titel
An Overview of Links Between Obesity and Mental Health
verfasst von
Christian Avila
Alison C. Holloway
Margaret K. Hahn
Katherine M. Morrison
Maria Restivo
Rebecca Anglin
Valerie H. Taylor
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Current Obesity Reports / Ausgabe 3/2015
Elektronische ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-015-0164-9

Weitere Artikel der Ausgabe 3/2015

Current Obesity Reports 3/2015 Zur Ausgabe

The Obesity Epidemic: Causes and Consequences (A Peeters and S Tanamas, Section Editors)

How Can We Better Prevent Obesity in Children?

Health Services and Programs (SFL Kirk, Section Editor)

Obesity Genes, Personalized Medicine, and Public Health Policy

The Obesity Epidemic: Causes and Consequences (A Peeters and S Tanamas, Section Editors)

Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem

The Obesity Epidemic: Causes and Consequences (A Peeters and S Tanamas, Section Editors)

The Double Burden of Undernutrition and Overnutrition in Developing Countries: an Update

Health Services and Programs (SFL Kirk, Section Editor)

Ethical Issues for Public Health Approaches to Obesity

The Obesity Epidemic: Causes and Consequences (A Peeters and S Tanamas, Section Editors)

Weight Management in Older Adults

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise